Why can’t investors think for themselves? How do parents cope with inexplicable tragedy? And is tech prepared for the toughest parts of health care?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, we dig into the potential merger of Bristol-Myers Squibb and Celgene, explaining the obscure but powerful firms that could sway whether shareholders approve the deal. Then, STAT’s Eric Boodman joins us to talk about his story on the emotional toll, scientific suspense, and bureaucratic frustration that confronts parents whose infants unexpectedly die. Then we delve into an unforeseen challenge that many digital health startups are facing: What to do when patients use their platforms to express that they’re feeling suicidal?
For more on what we cover, here’s an explanation of shareholder advisers; here’s Eric’s story on SIDS; and here’s the news on digital health and suicidal warnings.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
